No deviation, a patient-centric solution provider for the pharmaceutical industry is pleased to announce its partnership with Kneat Solutions, the leading validation software solution for the life sciences sector. The partnership between No deviation and Kneat Solutions enables them to work strategically with organizations to comprehensively map, configure, optimise and digitise work processes to KneatGx™, support deployment and provide on-going support, whether it is a single process at one site, or involves large scale deployments covering multiple sites and hundreds of users.
Kneat Solutions’ feature rich paperless validation platform, KneatGx™ makes validation easier, faster and smarter. Purpose built for the Life Sciences, KneatGx™ digitizes your entire validation life-cycle, enabling validation teams to author, review, approve, test-execute, manage exceptions and post-approve any business process in a 21 CFR Part 11 compliant web based software that’s securely accessible anywhere with an internet connection.
Trusted by over half of the world’s Top 20 Pharma Companies and with over 3000 users globally, KneatGx™ allows organizations to achieve and lock-down quality assurance best practice across an unlimited number of sites and users, to improve validation productivity by as much as 100% and significantly reduce time-to-market, changeover and cycle-times.
From a single process at one site, to large scale deployments covering multiple sites and hundreds of users – Kneat Solutions and our partners work closely with your organization to comprehensively map, optimize and digitize your work processes, deploy and provide on-going support.
A standalone ‘Software as a Service’ (SaaS) enterprise solution, KneatGx™ is hosted in private, qualified and highly secure Amazon Web Services (AWS) web servers. Simply deploy, configure and use Kneat securely online.
About Kneat Solutions
Kneat, a Canadian company with operational headquarters in Limerick, Ireland, develops and markets the next generation Kneat Gx software platform (“Kneat Gx”). Multiple business processes can be configured on Kneat Gx, from equipment to computer system validation, through to quality document management. Kneat Gx allows users to author, review, approve, execute testing online, manage any exceptions and post approve final deliverables in a controlled FDA 21 CFR Part 11/ Eudralex Annex 11 compliant platform. Macro and micro report dashboards enable powerful oversight into all systems, projects and processes world-wide. Customer case studies are reporting productivity improvements in excess of 100% and a higher data integrity and compliance standard. For more information visit www.kneat.com.
About No deviation
No deviation offers personalised focused solutions for the pharmaceutical industry, in engineering consultancy, and regulatory quality and compliance. With a sharp focus on delivering value-adding commissioning, qualification and validation services, they are leading experts in developing the lean CQV methodology. The company places keen attention on patient safety, process understanding, regulatory compliance and efficiency in the areas of safety, quality, cost and delivery.
No deviation believes in a holistic approach to achieving a successful execution derived from the principles of Understand, Observe, Define and Implement, which take their origin from ICHQ9. Whether as part of an integrated team, or overall scope management, the company delivers effective results from tapping into its team’s vast knowledge and experience in the field. Learn more at https://nodeviation.com/
If you have any questions regarding paperless validation and our partnership with Kneat Solutions, please contact us at email@example.com.
Pierre is a Chemical Engineer and the CEO of No deviation. He likes to develop a team vision for quality accountability and innovation. He is hugely optimistic and sees the opportunity in every task he undertakes.